ROTTERDAM (GenomeWeb) – Whole-genome sequencing of tumor biopsies has helped more than 200 advanced cancer patients in the Netherlands obtain off-label treatment with an anti-cancer drug so far, providing a clinical benefit for about a third of them, according to a presentation at the Association for Molecular Pathology's AMP Europe 2018 meeting here yesterday.
Paul Roepman, a clinical molecular biologist at the Hartwig Medical Foundation in Amsterdam, presented the results as part of an update on a Dutch national initiative, under which the foundation provides whole